Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Poshmark $318.8 million IPO
The shares are listed on the Nasdaq Global Select Market
Affirm Holdings $1.39 billion IPO
The shares are listed on the Nasdaq Global Select Market
IHS Markit joint venture with CME Group
We are advising IHS Markit on its agreement with CME Group to combine their post-trade services into a new joint venture
Cerberus Capital Management investment in Comscore
We are advising Cerberus as it joins with two other investors in an aggregate $204 million investment
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
Mirion Technologies acquisition of Sun Nuclear and related financing
We advised Mirion on the acquisition and incremental term loan credit facility
Fiera Capital sale of Bel Air Investment Advisors to Hightower Advisors
We are advising Fiera Capital on the transaction, which is expected to close in the first quarter of 2021
Smith-Cooper International acquisition of ABZ and Quadrant Valve brands
We advised Anvil/Smith-Cooper on the $105 million purchase of assets from Forum Energy Technologies
McCormick $710 million acquisition of FONA International
Davis Polk advised McCormick & Company Inc. in connection with its $710 million acquisition of FONA International, LLC…
cxLoyalty Group Holdings sale of Global Loyalty division to JPMorgan Chase
Davis Polk is advising cxLoyalty Group Holdings, Inc. in connection with its definitive agreement to sell its Global Loyalty…